Edda L Gomez-Panzani

Suggest Changes
Learn More
OBJECTIVE To evaluate the efficacy and safety of lanreotide depot/autogel 120 mg for the control of carcinoid syndrome (CS) symptoms in patients with neuroendocrine tumors (NETs). METHODS This was(More)
  • 1